Customer Login
You are not currently logged in.
Click Here to login to our secure customer site.
Improving our customers’ efficiency, accuracy & profitability using our
innovative technology, exceptional service & industry expertise
 
 
 
 
 
Proposal to Reduce DuoNeb Xopenex Reimbursement
ASHEVILLE, NORTH CAROLINA (May 11, 2006)
A draft local coverage determination (LCD), issued at the beginning of April, calls for Xopenex to be paid as Albuterol, while payment for DuoNeb would be based on the allowance for separate unit dose vials of Albuterol and Ipratropium. Recently released pricing for the second quarter of 2006 saw increases for Xopenex (18 cents per dose to $3.53) and DuoNeb (7 cents to $1.09 per dose). Under the proposed changes, Xopenex would be reimbursed at 18 cents a dose and DuoNeb at 28.8 cents per dose. Providers had until May 8 to comment on the proposal.
Provider Action: If any fee schedule changes are made by CMS, Allwin Data will update the system accordingly.

 Error

Web Part Error: A Web Part or Web Form Control on this Page cannot be displayed or imported. The type could not be found or it is not registered as safe.

Error Details:
[UnsafeControlException: A Web Part or Web Form Control on this Page cannot be displayed or imported. The type could not be found or it is not registered as safe.]
  at Microsoft.SharePoint.ApplicationRuntime.SafeControls.GetTypeFromGuid(Guid guid)
  at Microsoft.SharePoint.WebPartPages.SPWebPartManager.CreateWebPartsFromRowSetData(Boolean onlyInitializeClosedWebParts)
Privacy Statement | Terms of Use | eRx Network, eRx, Allwin Data, its logo and product names are registered trademarks of Electronic Rx Network, LLC
Go Search